WHO Study Group on Tobacco Product Regulation: Report on the Scientific Basis of Tobacco Product Regulation: Seventh Report of a WHO Study Group

Details

• Corporate Authors:
  World Health Organization
• Description:
  Effective tobacco product regulation is an essential component of a comprehensive tobacco control programme. It includes regulation of contents and emissions by mandated testing, disclosure of test results, setting limits, as appropriate, and imposing standards for product packaging and labelling. Tobacco product regulation is covered under Articles 9, 10 and 11 of the WHO Framework Convention on Tobacco Control (WHO FCTC) and in the partial guidelines on implementation of Articles 9 and 10. Other WHO resources, including the basic handbook on tobacco product regulation and the handbook on building laboratory testing capacity, support Member States in this area. The WHO Study Group on Tobacco Product Regulation (TobReg) was formally constituted by the Director-General of WHO in 2003 to address gaps in the regulation of tobacco products. Its mandate is to provide evidence-based policy recommendations on tobacco product regulation to the Director-General. TobReg is composed of national and international scientific experts on product regulation, treatment of tobacco dependence, toxicology and laboratory analyses of tobacco product ingredients and emissions. The experts come from countries in all six WHO regions. As a formalized entity of WHO, TobReg submits technical reports to the WHO Executive Board through the Director-General to draw the attention of Member States to the Organization's work in tobacco product regulation. The technical reports are based on unpublished background papers that have been discussed, evaluated and reviewed by TobReg. The ninth meeting of TobReg took place in Minneapolis, United States of America, on 5-7 December 2017, and was generously hosted by the Masonic Cancer Center, University of Minnesota, USA. The participants discussed priorities in the regulation of nicotine and novel and tobacco products and addressed requests from the WHO FCTC Conference of the Parties (COP) made at its seventh session, as outlined in documents FCTC/COP7(4), FCTC/COP7(9) and FCTC/COP7(14). The requests included the following. Continue to monitor and examine market developments and usage of novel and emerging tobacco products, such as heated tobacco products; Collect scientific information on the chemicals in the contents and emissions of smokeless tobacco products that contribute to their toxicity, addictiveness and attractiveness, on analytical methods for measuring them and on the levels in products on the market; and identify technical approaches for reducing toxicants in smokeless tobacco; Promote research on culturally relevant interventions to prevent the uptake of waterpipe tobacco smoking and to promote quitting (cessation); the epidemiology of use; acute and chronic health risks; cultural practices; initiation and maintenance of use; the influence of flavourings on initiation, maintenance of use and increasing use; risk of dependence on low-nicotine tobacco products; and effective policies based on concepts such as information technology and communications. In response to these requests, WHO commissioned the following background papers: Heated tobacco products (section 2); Clinical pharmacology of nicotine in electronic nicotine delivery systems (section 3); A global nicotine reduction strategy: state of the science (section 4); A regulatory strategy for reducing exposure to toxicants in cigarette smoke (section 5); The science of flavour in tobacco products (section 6); Sugar content of tobacco products (section 7); Updated priority list of toxicants in combusted tobacco products (section 8); Approaches to measuring and reducing toxicant concentrations in smokeless tobacco products (section 9); Waterpipe tobacco smoking: prevalence, health effects and interventions to reduce use (section 10). [Description provided by NIOSH]
• Subjects:
  Flavoring Agents Nicotine Occupational Health Safety Smokers Tobacco Products
• Keywords:
  Cigarette Manufacturing Control Methods Flavorings Health Effects Policy Regulations Smoking Tobacco
• ISBN:
  9789241210249
• ISSN:
  0512-3054
• Publisher:
  World Health Organization
• Document Type:
  Text
• Funding:
  Grant
• Genre:
  Book
• Place as Subject:
  California ; Minnesota ; OSHA Region 5 ; OSHA Region 9
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  1-260
• NIOSHTIC Number:
  nn:20063052
• Citation:
  WHO Technical Report Series, No. 1015. Geneva, Switzerland: World Health Organization, 2020 Oct; :1-260
• CAS Registry Number:
  (-)-Nicotine (CAS RN 54-11-5)
• Federal Fiscal Year:
  2021
• Performing Organization:
  University of California, Berkeley
• Peer Reviewed:
  False
• Start Date:
  20050701
• Source Full Name:
  WHO study group on tobacco product regulation: report on the scientific basis of tobacco product regulation: seventh report of a WHO study group
• End Date:
  20250630
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:f41a54f988079d17cb4b30881b53ac664ef4d17a8d44155bcf55ae1c54a1f7872f030151576d3a5219f917bcacd5e962eb20c53a77208059712b5bb69b137524
• Download URL:
  https://stacks.cdc.gov/view/cdc/226181/cdc_226181_DS1.pdf
• File Type:
  [PDF - 2.92 MB ]